SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-105924
Filing Date
2024-04-23
Accepted
2024-04-23 07:36:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d823645ddefa14a.htm DEFA14A 24095
  Complete submission text file 0001193125-24-105924.txt   25120
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39344 | Film No.: 24862707
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)